Is NRG2α Fusion a "Doppelgänger" to NRG1α/β Fusions in Oncology?

J Thorac Oncol. 2020 Jun;15(6):878-880. doi: 10.1016/j.jtho.2020.02.020.

Authors

Misako Nagasaka¹, Sai-Hong Ignatius Ou²

Affiliations

¹ Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan; Department of Advanced Medical Innovation, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
² Chao Family Comprehensive Cancer Center, Department of Medicine, Division of Hematology-Oncology, University of California Irvine School of Medicine, Orange, California. Electronic address: siou@hs.uci.edu.

PMID: 32471560
DOI: 10.1016/j.jtho.2020.02.020

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adenocarcinoma of Lung*
Humans
Japan
Lung Neoplasms* / genetics
Neuregulin-1
Smokers

Substances

Neuregulin-1